Randomized trial of thymectomy in myasthenia gravis

New England Journal of Medicine

Volumn 375, Issue 6, 2016, Pages 511-522

  Wolfe, G I ^a   Kaminski, H J ^d   Aban, I B ^e   Minisman, G ^e   Kuo, H C ^e   Marx, A ^f   Strobel P ^g   Mazia, C ⁱ   Oger, J ^j   Cea, J G ^l   Heckmann, J M ^m   Evoli, A ⁿ   Nix, W ^h   Ciafaloni, E ^b   Antonini, G ^o   Witoonpanich, R ^p   King, J O ^q   Beydoun, S R ^r   Chalk, C H ^k   Barboi, A C ^t   Amato, A A ^u   Shaibani, A I ^v   Katirji, B ^x   Lecky, B R F ^z   Buckley, C ^aa   Vincent, A ^aa   Dias Tosta, E ^ab   Yoshikawa, H ^ae   Waddington Cruz, M ^ac   Pulley, M T ^af   Rivner, M H ^ah   Kostera Pruszczyk, A ^ai   Pascuzzi, R M ^aj   Jackson, C E ^w   Garcia Ramos, G S ^ak   Verschuuren, J J G M ^al   Massey, J M ^am   Kissel, J T ^y   Werneck, L C ^ad   Benatar, M ^ag   Barohn, R J ^an   Tandan, R ^ao   Mozaffar, T ^s   Conwit, R ^ap   Odenkirchen, J ^ap   Sonett, J R ^c   Jaretzki, A ^c   Newsom Davis, J ^aa   Cutter, G R ^e   more..

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c Department of Medicine   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g UNIVERSITY OF GÖTTINGEN   (Germany)

^h JOHANNES GUTENBERG UNIVERSITY   (Germany)

ⁱ UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^k MCGILL UNIVERSITY   (Canada)

^l UNIVERSITY OF CHILE   (Chile)

^m UNIVERSITY OF CAPE TOWN   (South Africa)

ⁿ CATHOLIC UNIVERSITY   (Italy)

^o SAPIENZA UNIVERSITY OF ROME   (Italy)

^p MAHIDOL UNIVERSITY   (Thailand)

^q UNIVERSITY OF MELBOURNE   (Australia)

^r UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^s UNIVERSITY OF CALIFORNIA   (United States)

^t MEDICAL COLLEGE OF WISCONSIN   (United States)

^u HARVARD MEDICAL SCHOOL   (United States)

^v Nerve and Muscle Center of Texas   (United States)

^w UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^x CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^y THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^z WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^aa UNIVERSITY OF OXFORD   (United Kingdom)

^ab UNIVERSITY OF BRASILIA   (Brazil)

^ac FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^ad FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^ae KANAZAWA UNIVERSITY   (Japan)

^af UNIVERSITY OF FLORIDA   (United States)

^ag UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^ah MEDICAL COLLEGE OF GEORGIA   (United States)

^ai MEDICAL UNIVERSITY OF WARSAW   (Poland)

^aj INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ak INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^al LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^am DUKE UNIVERSITY MEDICAL CENTER   (United States)

^an UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^ao UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^ap NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE DURATION; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYASTHENIA GRAVIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THYMECTOMY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; ADOLESCENT; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; HOSPITALIZATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; SEVERITY OF ILLNESS INDEX; SINGLE BLIND PROCEDURE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PREDNISONE; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; THYMECTOMY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84981743104     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1602489     Document Type: Article

References (33)

1. Blalock A, Harvey AM, Ford FR, Lilienthal JL. The treatment of myasthenia gravis by removal of the thymus gland. JAMA 1941;117:1529-33.
2. McQuillen MP, Leone MG. A treatment carol: thymectomy revisited. Neurology 1977;27:1103-6.
3. Oosterhuis HJ. Observations of the natural history of myasthenia gravis and the effect of thymectomy. Ann N Y Acad Sci 1981;377:678-90.
4. Rodriguez M, Gomez MR, Howard FM Jr, Taylor WF. Myasthenia gravis in children: long-term follow-up. Ann Neurol 1983;13:504-10.
5. Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve 2008;37:141-9.
6. Lanska DJ. Indications for thymectomy in myasthenia gravis. Neurology 1990;40:1828-9.
7. Cea G, Benatar M, Verdugo RJ, Salinas RA. Thymectomy for non-thymomatous myasthenia gravis. Cochrane Database Syst Rev 2013;10:CD008111.
8. Gronseth GS, Barohn RJ. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:7-15.
9. Pascuzzi RM, Coslett HB, Johns TR. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients. Ann Neurol 1984;15:291-8.
10. Healthcare Cost and Utilization Project: nationwide inpatient sample. Rockville, MD: Agency for Healthcare Research and Quality (http://www.hcup-us.ahrq.gov/).
11. Jaretzki A III, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Neurology 2000;55:16-23.
12. Newsom-Davis J, Cutter G, Wolfe GI, et al. Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone. Ann N Y Acad Sci 2008;1132:344-7.
13. Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan WW. Reliability testing of the Quantitative Myasthenia Gravis score. Ann N Y Acad Sci 1998;841:769-72.
14. Bedlack RS, Simel DL, Bosworth H, Samsa G, Tucker-Lipscomb B, Sanders DB. Quantitative Myasthenia Gravis score: assessment of responsiveness and longitudinal validity. Neurology 2005;64:1968-70.
15. Moons P, De Geest S, Abraham I, Cleemput JV, Van Vanhaecke J. Symptom experience associated with maintenance immunosuppression after heart transplantation: patients' appraisal of side effects. Heart Lung 1998;27:315-25.
16. Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ. Myasthenia Gravis Activities of Daily Living profile. Neurology 1999;52:1487-9.
17. Muppidi S, Wolfe GI, Conaway M, Burns TM. MG-ADL: still a relevant outcome measure. Muscle Nerve 2011;44:727-31.
18. Muscle Study Group. A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis. Neurology 2008;71:394-9.
19. Sanders DB, Hart IK, Mantegazza R, et al. An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis. Neurology 2008;71:400-6.
20. Conti-Fine BM, Diethelm-Okita B, Ostlie N, Wang W, Milani M. Immunopathogenesis of myasthenia gravis. In: Kaminski HJ, ed. Myasthenia gravis and related disorders. New York: Humana Press, 2009:43-70.
21. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330:1797-810.
22. Berrih-Aknin S, Le Panse R. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun 2014;52:90-100.
23. Alshekhlee A, Miles JD, Katirji B, Preston DC, Kaminski HJ. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology 2009;72:1548-54.
24. Jaretzki A III Thymectomy for myasthenia gravis: analysis of the controversies regarding technique and results. Neurology 1997;48:Suppl 5:S52-63.
25. Lee CY, Kim DJ, Lee JG, Park IK, Bae MK, Chung KY. Bilateral video-assisted thoracoscopic thymectomy has a surgical extent similar to that of transsternal extended thymectomy with more favorable early surgical outcomes for myasthenia gravis patients. Surg Endosc 2011;25:849-54.
26. Mack MJ, Landreneau RJ, Yim AP, Hazelrigg SR, Scruggs GR. Results of videoassisted thymectomy in patients with myasthenia gravis. J Thorac Cardiovasc Surg 1996;112:1352-9.
27. Mantegazza R, Baggi F, Bernasconi P, et al. Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients: remission after 6 years of follow-up. J Neurol Sci 2003;212:31-6.
28. Rückert JC, Swierzy M, Ismail M. Comparison of robotic and nonrobotic thoracoscopic thymectomy: a cohort study. J Thorac Cardiovasc Surg 2011;141:673-7.
29. Shrager JB, Deeb ME, Mick R, et al. Transcervical thymectomy for myasthenia gravis achieves results comparable to thymectomy by sternotomy. Ann Thorac Surg 2002;74:320-6.
30. Ponseti JM, Gamez J, Vilallonga R, et al. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis. Eur J Cardiothorac Surg 2008;34:1062-7.
31. Jaretzki A III, Penn AS, Younger DS, et al. "Maximal" thymectomy for myasthenia gravis: results. J Thorac Cardiovasc Surg 1988;95:747-57.
32. Masaoka A, Monden Y, Seike Y, Tanioka T, Kagotani K. Reoperation after transcervical thymectomy for myasthenia gravis. Neurology 1982;32:83-5.
33. Miller RG, Filler-Katz A, Kiprov D, Roan R. Repeat thymectomy in chronic refractory myasthenia gravis. Neurology 1991;41:923-4.